CNTA - Centessa Pharmaceuticals PLC ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNTA is currently covered by 8 analysts with an average price target of $44.8. This is a potential upside of $4.3 (10.62%) from yesterday's end of day stock price of $40.5.

Centessa Pharmaceuticals PLC ADR's activity chart (see below) currently has 56 price targets and 64 ratings on display. The stock rating distribution of CNTA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.11% with an average time for these price targets to be met of 338.81 days.

Highest price target for CNTA is $62, Lowest price target is $38, average price target is $44.8.

Most recent stock forecast was given by from WELLS FARGO on 20-Apr-2026. First documented stock forecast 22-Jun-2021.

Best performing analysts who are covering CNTA - Centessa Pharmaceuticals PLC ADR:

Biren Amin Danielle Brill Rudy Li Kostas Biliouris Benjamin Burnett

Currently out of the existing stock ratings of CNTA, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Sep-2025

$42

$1.5 (3.70%)

$35

6 months 2 days ago
(20-Apr-2026)

3/4 (75%)

$2.49 (6.30%)

164

Buy Since 12-Jun-2023

$43

6 months 20 days ago
(02-Apr-2026)

6/7 (85.71%)

$14.64 (51.62%)

243

Buy Since 17-Mar-2023

$40

$-0.5 (-1.23%)

$24

6 months 21 days ago
(01-Apr-2026)

3/3 (100%)

$0.14 (0.35%)

163

Buy Since 08-May-2025

$40

6 months 21 days ago
(31-Mar-2026)

4/4 (100%)

$13.5 (50.94%)

190

Buy Since 31-Mar-2025

$38

8 months 6 days ago
(15-Feb-2026)

3/3 (100%)

$15.8 (71.17%)

252

Show more analysts

Please expand the browser size to see the chart

What is CNTA (Centessa Pharmaceuticals PLC ADR) average time for price targets to be met?

On average it took 339 days for the stock forecasts to be reached, with an average price target met ratio of 89.11%.

Which analyst most recently updated their price target on CNTA (Centessa Pharmaceuticals PLC ADR)?

Which analyst has the most public recommendations on CNTA (Centessa Pharmaceuticals PLC ADR)?

has 0 price targets and 0 ratings on CNTA

Which analyst is the currently most bullish on CNTA (Centessa Pharmaceuticals PLC ADR)?

Kostas Biliouris with the highest potential upside of $21.5

Which analyst is the currently most reserved on CNTA (Centessa Pharmaceuticals PLC ADR)?

Eun Yang with the lowest potential downside of -$36.5
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?